A yeast chemical genetics approach identifies the compound 3,4,5-trimethoxybenzyl isothiocyanate as a calcineurin inhibitor  by Prescott, Thomas A.K. et al.
FEBS Letters 588 (2014) 455–458journal homepage: www.FEBSLetters .orgA yeast chemical genetics approach identiﬁes the compound
3,4,5-trimethoxybenzyl isothiocyanate as a calcineurin inhibitor0014-5793/$36.00  2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2013.12.006
⇑ Corresponding author. Fax: +44 208 332 5310.
E-mail addresses: t.prescott@kew.org (T.A.K. Prescott), barry.panaretou@kcl.a-
c.uk (B. Panaretou).Thomas A.K. Prescott a,⇑, Barry Panaretou b, Nigel C. Veitch a, Monique S.J. Simmonds a
aRoyal Botanic Gardens, Kew, Richmond, Surrey TW9 3AB, UK
b Institute of Pharmaceutical Science, Franklin-Wilkins Building, London SE1 9NH, UK
a r t i c l e i n f o a b s t r a c tArticle history:
Received 30 September 2013
Revised 10 December 2013
Accepted 11 December 2013
Available online 24 December 2013
Edited by Miguel De la Rosa
Keywords:
3,4,5-Trimethoxybenzyl isothiocyanate
Calcineurin
Yeast
Haploinsufﬁciency screen
Iberis saxatilisThe phosphatase enzyme calcineurin controls gene expression in a variety of biological contexts
however few potent inhibitors are currently available. A screen of 360 plant extracts for inhibition
of calcineurin-dependent gene expression in the model organism Saccharomyces cerevisiae identi-
ﬁed the compound 3,4,5-trimethoxybenzyl isothiocyanate as an inhibitor. The compound was sub-
sequently shown to inhibit human calcineurin via a mixed inhibition mechanism. To gain further
mechanistic insight a yeast haploinsufﬁciency screen of 1152 deletion strains was carried out using
a novel liquid medium screening method. The resulting haploinsufﬁciency proﬁle is similar to that
reported for the known calcineurin inhibitor FK506.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Calcineurin is a serine/threonine phosphatase enzyme which
acts though its role in the calcineurin pathway to modulate gene
expression in a variety of biological contexts [1,2]. Calcineurin ex-
erts its control over eukaryotic gene expression by dephosphoryl-
ating NFAT peptides which then translocate to the nucleus and
bind to the promoters of calcineurin-dependent genes [3]. Calci-
neurin is activated by the calcium sensing protein calmodulin,
thereby linking calcium signalling to gene expression [3]. Its role
is well documented in human T-cells where it controls activation
and proliferation via cytokine expression [4]. It has also been ac-
tively studied in Saccharomyces cerevisiae, where calcineurin-
dependent gene expression has been shown to promote cell wall
integrity and tolerance to ion stress [5]. Elucidating the role of
the calcineurin pathway in different biological contexts has been
greatly aided by the fungal derived calcineurin inhibitors FK-506
and cyclosporine, although these compounds act indirectly via
peptidyl-prolyl cis–trans isomerases rather than binding to the en-
zyme itself [6]. Compounds that bind to and inhibit calcineurin di-
rectly, such as the marine sponge metabolite okadaic acid, have
been reported but few exhibit selective inhibition [6]. The intensity
with which fungal natural products have been screened forcalcineurin inhibitors contrasts with plant secondary metabolites
where potent calcineurin inhibitors have yet to be reported. We
therefore initiated a screen of plant extracts with the aim of ascer-
taining if potent calcineurin inhibitors can be found in higher
plants. From a library of 360 plant extracts, an active extract was
identiﬁed and the active metabolite isolated and investigated fur-
ther with calcineurin in a cell-free system. As the compound exerts
a growth inhibitory effect on yeast we were able to use haploinsuf-
ﬁciency proﬁling to determine if the compound possesses other
‘‘off target’’ secondary mechanisms or if calcineurin is the principle
target. As the compound is not stable in molten agar a simpliﬁed
liquid medium screening method was developed that can be car-
ried out without the aid of a liquid handling robot. The screen iden-
tiﬁed seven hypersensitive yeast strains with genes involved in
transcription predominating.
2. Materials and methods
2.1. Screen of plant extract library and isolation of TMBITC
The plant extract library comprises 360 principally European
species extracted from lyophilised plant material with DMSO and
stored at80 C in a 96well plate format. The extractswere assayed
at 1%v/vusing theyeast calcineurin reporter assay (Section2.3). Leaf
and stem of Iberis saxatilis L. (Brassicaceae) (Voucher: T. Prescott BI-
21302 (K)) was collected at Kew as described previously [7]. The
Fig. 1. 3,4,5-Trimethoxybenzyl isothiocyanate (TMBITC) from I. saxatilis.
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MeOHextract to a singleHPLCpeakwhichwasused as a reference to
guide subsequent isolation. Plant material (60 g) was extracted
twice with 500 ml methanol, ﬁltered and concentrated before elut-
ing from a C-18 Flash column. Final puriﬁcation on a Waters HPLC
system ﬁtted with a Supelcosil LC-18 column (250  10 mm i.d.,
5 lm particle size) yielded 102.5 mg of a white amorphous solid.
2.2. Structure elucidation of TMBITC
NMR spectra of 3,4,5-trimethoxybenzyl isothiocyanate
(TMBITC) were acquired in MeOH-d4 at 30 C on a Bruker 400
(Avance) MHz instrument. Standard pulse sequences and parame-
ters were used to obtain one-dimensional 1H and 13C, and two-
dimensional gradient-enhanced HSQC and HMBC spectra. Chemi-
cal shift referencing was carried out using the internal solvent res-
onances at dH 3.31 and dC 49.1 (calibrated to TMS at 0.00 ppm).
HRESIMS data were obtained on a Thermo Scientiﬁc LTQ-Orbitrap
XL hybrid ion trap–orbitrap instrument. 1H NMR (MeOH-d4,
400 MHz): d 6.66 (2H, s, H-2/6), 4.68 (2H, s, CH2NCS), 3.84 (6H, s,
3/5-OCH3), 3.76 (3H, s, 4-OCH3); 13C NMR (MeOH-d4, 100 MHz):
d 155.0 (C-3/5), 139.2 (C-4), 134.3 (NCS), 132.5 (C-1), 105.7 (C-2/
6), 61.2 (4-OCH3), 56.8 (3/5-OCH3), 49.7 (CH2NCS). HRESIMS m/z:
240.0691 [M+H]+ (calc. for C11H14NO3S+, 240.0689).
2.3. Yeast calcineurin reporter gene assay
The assay followed the method previously reported [8] using S.
cerevisiae BY4741 transformed with the plasmid pAMS366 which
contains four copies of a calcineurin-dependent response element
to drive transcription of LacZ [9].
2.4. Calcineurin enzyme phosphatase assays
Assays were performed using the calcineurin assay kit
(Enzo Life Sciences, UK) adapted for use in a 384 well plate as
described previously [8]. Dephosphorylation of the RII peptide
(DLDVPIPGRFDRRVpSVAAE) by calcineurin was measured by
detection of free phosphate using a malachite green reagent
included with the kit. Lineweaver-Burke plots were produced
using essentially the same method, varying the concentration of
RII peptide substrate between 136 lM and 40 lM with inhibitor
concentrations of zero, 20.9 lM and 41.7 lM.
2.5. Yeast haploinsufﬁciency screen
A simpliﬁed liquid media screening method was developed
with initial inoculation by pin tool carried out directly into the ﬁnal
test plate. This approach allows the numerical readout from repli-
cates of each yeast strain to be averaged. The ‘‘yeast essential col-
lection’’ comprising 1152 heterozygous knock-out yeast strains
was purchased from Thermo Scientiﬁc, UK and re-arrayed into
384 well plate format in 15% glycerol to produce a library of 3
plates which was stored at 80 C.
To carry out the screen, ﬁfteen polystyrene, clear, ﬂat bottomed
384 well plates (Fisher Scientiﬁc, UK) were ﬁlled with 10 ll YPD
medium using an Integra Viaﬂo 16 channel electronic pipette set
to repeat dispense mode. The plates were then inoculated from
the glycerol plate library using a 384 well pin tool (Boekel Scien-
tiﬁc, USA). Pin tool sterilization was achieved with 10% sodium
hypochlorite followed by 5 rinses with sterile dH2O before ﬁnal
sterilization with 90% ethanol. Each of the three plates of the glyc-
erol stock yeast library were replicated into ﬁve of the YPD med-
ium containing plates so as to inoculate all 15 plates with each
cell line represented ﬁve times. The plates were then incubated
overnight at 30 C to allow cells to reach stationary phase and soequalize cell density; evaporation was minimised by partially seal-
ing the plates in zip lock bags. Growth was then re-initiated by
adding 80 ll YPD containing TMBITC by contactless pipetting to
make a ﬁnal concentration of 4 lg/ml (16.7 lM). Optical density
at 600 nm was measured inside each well in 9 separate locations
in a three by three grid using a Tecan Inﬁnite M200 plate reader
with the plate lid removed. After 7 h incubation at 30 C the plates
were read using the same method and the two readings used to
establish increase in growth. Despite the high starting cell density
in each well the growth curve of individual strains was observed to
contain a log phase (data not shown).
Strains identiﬁed in the screen were retested by measuring a
complete growth curve over 22.5 h with and without TMBITC. Late
log phase cells were diluted to OD600 0.02 with YPD medium using
a 1 cm path length cuvette spectrophotometer. The cell suspension
was added 25 ll per well to a 384 well plate containing 25 ll per
well drug dilutions in YPD. Each well was read every 550 s for
22.5 h with the plate lid on while incubating at 30 C.
3. Results
3.1. Screening a library of plant extracts identiﬁes TMBITC as a
calcineurin inhibitor in yeast
I. saxatilis was identiﬁed as active by screening 360 DMSO plant
extracts for calcineurin inhibitors using a yeast calcineurin repor-
ter strain that expresses the LacZ gene under the control of a calci-
neurin-dependent response element. Subsequent activity-guided
puriﬁcation yielded TMBITC (Fig. 1), which was characterised by
NMR spectroscopy (Section 2.3). TMBITC inhibits yeast calcineu-
rin-dependent gene expression with an IC50 of 5.2 lM compared
with 0.56 lM for the immunosuppressant calcineurin inhibitor
FK-506 (Fig. 2A).
3.2. TMBITC inhibits human calcineurin by a mixed inhibition
mechanism
Since calcineurin-dependent gene expression can be inhibited
at numerous different points in the calcineurin pathway, TMBITC
was assayed directly against calmodulin activated calcineurin to
establish whether it acts as a direct inhibitor. As Fig. 2B illustrates,
the compound inhibited calcineurin phosphatase activity with an
IC50 of 21.5 lM. In order to determine the mode of inhibition by
TMBITC, reaction velocities were measured at varying concentra-
tions of TMBITC and RII phosphopeptide substrate. As can be seen
in the Lineweaver Burke plot (Fig. 2C), linear regression produces
lines that intersect in a position consistent with a reversible mixed
inhibition mechanism.
3.3. A yeast haploinsufﬁciency screen identiﬁes hypersensitive strains
with related functions
To gain a better understanding of the mechanisms behind the
growth inhibitory effects of TMBITC a yeast haploinsufﬁciency
screen was carried out. This was enabled by the activity of TMBITC
on S. cerevisiae BY4743 with complete growth inhibition observed
in liquid YPD medium at 16 lg/ml (66.8 lM). The haploinsufﬁcien-
cy screen was carried out using plate reader optical density
Fig. 2. TMBITC inhibits calcineurin-dependent gene expression in yeast and recombinant human calcineurin. (A) Inhibition of yeast calcineurin-dependent gene expression
by TMBITC (triangles) and the calcineurin inhibitor FK-506 (squares). Error bars (S.E.M. N = 8) are generally smaller than data point markers. (B) Inhibition of recombinant
human calcineurin by TMBITC. Error bars show S.E.M. (N = 3). (C) TMBITC inhibits human calcineurin via a mixed inhibition mechanism. Substrate concentrations of RII
peptide were varied from 136 lM to 40 lM and inhibitor concentrations were 0, 20.9 lM and 41.7 lM. Each reaction was carried out in triplicate.
Fig. 3. Growth curves of individual yeast deletion strains identiﬁed with the haploinsufﬁciency screen. In each case the upper growth curve is no drug (vehicle only) and the
lower curve is 8.4 lM (2 lg/ml) TMBITC. Hypersensitive strains exhibit a greater difference between treated and untreated growth curves relative to the BY4743 control
strain. Readings were taken every 550 s. Each growth curve is composed of 145 time points and each time point is an average of 12 replicates. Each replicate is an average of 9
readings taken in separate locations inside each well. Between 10 h and 20 h standard error of the mean for each time point does not exceed 0.13.
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ent yeast strains. A screening dose of 4 lg/ml (16.7 lM) was se-
lected so as to give sublethal inhibition. The screen produced a
shortlist of potentially hypersensitive strains which were exam-
ined in more detail by recording a growth curve in the presence
and absence of 2 lg/ml (8.4 lM) TMBITC (Fig. 3) with each strain
manually adjusted to the same initial optical density. Seven yeast
strains exhibited hypersensitivity relative to the control strain
BY4743. Genes with functions relating to transcription, chromatin
dynamics and translation predominate, the single exception being
ARP3 which encodes for a component of the Arp2/3 actin nucle-
ation complex (Table 1).
4. Discussion
TMBITC, was identiﬁed as an inhibitor of yeast calcineurin-
dependent gene expression (IC50 5.2 lM) and produced a Linewe-aver Burke plot consistent with a mixed inhibition mechanism
using human calcineurin. Thus TMBITC either binds to calcineurin
in the presence and absence of substrate via a classic mixed inhibi-
tion mechanism or alternatively could bind to both calcineurin and
the activating protein calmodulin with varying afﬁnities. This is an
inhibition mechanism distinct from the well characterised calci-
neurin inhibitors cyclosporine and FK-506 which act indirectly
via peptidyl-prolyl cis–trans isomerases [6]. It also demonstrates
that reasonably potent calcineurin inhibitors can be found in
plants where their presence might be expected to contribute a
valuable form of antifungal defence.
A yeast haploinsufﬁciency screen was carried out to uncover
calcineurin-independent effects of the compound. A novel screen-
ing method was developed based on optical density readings in li-
quid media that uses minimal liquid handling steps so removing
the need for liquid handling robots. The method provides an
alternative to conventional pinning of yeast arrays on solid agar
Table 1
Hypersensitive strains identiﬁed in the yeast haploinsufﬁciency screen.
Gene ORF Gene function (GO term)
RET1 YOR207C tRNA transcription from RNA polymerase III promoter
RPC53 YDL150W tRNA transcription from RNA polymerase III promoter
ARP3 YJR065C Actin ﬁlament organization
RPL33A YPL143W Cytoplasmic translation
RSC58 YLR033W Chromatin remodelling
RRN6 YBL014C Transcription initiation from RNA polymerase I promoter
RSC9 YML127W ATP-dependent chromatin remodelling
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agar. Furthermore the method provides numerical readouts of
growth, which can be repeated and averaged to reduce error, as op-
posed to growth on solid medium where marginal differences in
colony size can be difﬁcult to detect by eye.
The haploinsufﬁciency screen identiﬁed seven hypersensitive
strains the two most sensitive of which carry deletions for genes
encoding different subunits of RNA polymerase III (RET1and
RPC53). RNA polymerase III is responsible for the transcription of
low molecular weight RNAs such as tRNA and 5S RNA genes that
are necessary for ribosomal assembly [10]. The third most sensitive
strain carries a deletion for the actin nucleation protein ARP3 and
is therefore unrelated in function to RNA polymerase III [11]. The
fourth most sensitive strain carries a deletion for RPL33A which
encodes a ribosomal 60S subunit protein [12] suggesting a link
with RNA polymerase III and the synthesis of rRNA. The remaining
hypersensitive strains all have functions that that are centred on
ribosomal RNA and chromatin remodelling. These are RSC58, a
component of the RSC chromatin remodelling complex [13],
RRN6 required for transcription of 35S rRNA genes [14] and RSC9
another component of the RSC complex [15]. Thus 5 of the 7 hyper-
sensitive strains identiﬁed carry deletions for genes with functions
related to transcription and chromatin dynamics. Interestingly, the
top three most sensitive strains identiﬁed in the screen which car-
ry deletions for RET1, RPC53 and ARP3 are all reported as sensitive
to the calcineurin inhibitor drug FK506 [16]. Thus the haploinsuf-
ﬁciency proﬁle of TMBITC indicates calcineurin inhibition, along-
side a secondary off target mechanism that is sensitive to the
deletion of transcription-related genes.
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